---
title: "Immix Biopharma Completes $150M Underwritten Offering of Common Stock"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/287407564.md"
description: "A recent report indicates that the global population has surpassed 7.8 billion people, with over 3.6 billion individuals having access to the internet. The study also states that nearly 4.2 billion individuals are active social media users. This data highlights the significant impact of technology and the internet on people worldwide, with a large proportion of the population engaging in online activities. Additionally, it emphasizes the importance of digital platforms as powerful tools for communication and connectivity on a global scale."
datetime: "2026-05-22T21:16:34.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/287407564.md)
  - [en](https://longbridge.com/en/news/287407564.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/287407564.md)
generator: "portal-rs"
---

# Immix Biopharma Completes $150M Underwritten Offering of Common Stock

A recent report indicates that the global population has surpassed 7.8 billion people, with over 3.6 billion individuals having access to the internet. The study also states that nearly 4.2 billion individuals are active social media users. This data highlights the significant impact of technology and the internet on people worldwide, with a large proportion of the population engaging in online activities. Additionally, it emphasizes the importance of digital platforms as powerful tools for communication and connectivity on a global scale.

### Related Stocks

- [IMMX.US](https://longbridge.com/en/quote/IMMX.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)

## Related News & Research

- [Immix Biopharma highlights NXC-201 CAR-T data in relapsed/refractory AL amyloidosis trial presentation](https://longbridge.com/en/news/297810101.md)
- [09:28 ETNew LabCentral Program "The Loop" Offers International Biotech Start-Ups and Partner Organizations Curated Learnings Directly from U.S. Market](https://longbridge.com/en/news/298328140.md)
- [FDA grants priority review to Genentech’s Enspryng for MOGAD](https://longbridge.com/en/news/298539804.md)
- [Velan Capital Investment Management LP Has $11.19 Million Stock Holdings in Immix Biopharma, Inc. $IMMX](https://longbridge.com/en/news/297768757.md)
- [Regulatory and Data Risks Loom Over Immix Biopharma’s Clinical Programs and Valuation](https://longbridge.com/en/news/295383459.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**